BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...bad practices,” said Nisa Leung, at Qiming Ventures. Qiming has invested in Chinese CRISPR company CureGenetics Co. Ltd....
...California Institute of Technology, Pasadena, Calif. China Ministry of Science and Technology (MOST), Beijing, China CureGenetics Co. Ltd....
BioCentury | Oct 19, 2018
Tools & Techniques

Allogeneic CARs on the horizon

...T cells,” said Yanni Lin, co-founder and chief technology officer of Chinese cell therapy company CureGenetics Co. Ltd....
...and is used by Allogene Therapeutics Inc. (NASDAQ:ALLO), Cellectis S.A. (NASDAQ:CLLS), CRISPR Therapeutics AG (NASDAQ:CRSP), CureGenetics Co. Ltd....
...histocompatibility complex class I (MHCI); insertion of a CD19-targeting CAR CRISPR Preclinical; IND this year CureGenetics Co. Ltd....
BioCentury | Aug 10, 2018
Financial News

China's CureGenetics raises $17M for CRISPR

...also said it plans to use the platform to develop CRISPR-based diagnostics. CureGenetics Co. Ltd., Suzhou, China Allison Johnson CureGenetics Co. Ltd. Qiming...
BioCentury | Aug 6, 2018
Financial News

Chinese CRISPR play CureGenetics raises $17M series A

CureGenetics Co. Ltd. (Suzhou, China) raised $17 million in a series A round led by new investor Qiming Venture Partners. CTS Capital and Ascendin Investment also participated. CureGenetics uses its CRISPR-based gene editing technology to...
Items per page:
1 - 4 of 4
BioCentury | Dec 1, 2018
Politics, Policy & Law

China’s germline growing pain

...bad practices,” said Nisa Leung, at Qiming Ventures. Qiming has invested in Chinese CRISPR company CureGenetics Co. Ltd....
...California Institute of Technology, Pasadena, Calif. China Ministry of Science and Technology (MOST), Beijing, China CureGenetics Co. Ltd....
BioCentury | Oct 19, 2018
Tools & Techniques

Allogeneic CARs on the horizon

...T cells,” said Yanni Lin, co-founder and chief technology officer of Chinese cell therapy company CureGenetics Co. Ltd....
...and is used by Allogene Therapeutics Inc. (NASDAQ:ALLO), Cellectis S.A. (NASDAQ:CLLS), CRISPR Therapeutics AG (NASDAQ:CRSP), CureGenetics Co. Ltd....
...histocompatibility complex class I (MHCI); insertion of a CD19-targeting CAR CRISPR Preclinical; IND this year CureGenetics Co. Ltd....
BioCentury | Aug 10, 2018
Financial News

China's CureGenetics raises $17M for CRISPR

...also said it plans to use the platform to develop CRISPR-based diagnostics. CureGenetics Co. Ltd., Suzhou, China Allison Johnson CureGenetics Co. Ltd. Qiming...
BioCentury | Aug 6, 2018
Financial News

Chinese CRISPR play CureGenetics raises $17M series A

CureGenetics Co. Ltd. (Suzhou, China) raised $17 million in a series A round led by new investor Qiming Venture Partners. CTS Capital and Ascendin Investment also participated. CureGenetics uses its CRISPR-based gene editing technology to...
Items per page:
1 - 4 of 4